Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Medicare Drug Benefit: Impact on States, and Cost Containment

Medicare Drug Benefit: Impact on States, and Cost Containment

This presentation outlines key Medicare Modernization Act issues for Medicaid, State Pharmaceutical Assistance Programs, other state agencies, and state employee retiree benefit plans. It also reviews Medicaid cost-containment options being considered in the states related to eligibility, benefits, unit cost, utilization, managed care, revenue enhancement and cost avoidance, and administrative efficiencies.

Blog Post

#TBT: Value-Based Insurance Design & New Medicare Advantage Model

As part of our Throwback Thursday blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research...
Blog Post

CER Tweets of the Week: Study on Six Potential EBM “Biases”; VBID "Gets Its Medicare Close-up" (August 31-September 4)

This week on Twitter, comparative effectiveness research (CER) stakeholders shared a study examining six potential biases against patients and carers...
Newsletter Volume

E.V.I.dently June 2015

NPC MessageDriving Health System Value Through Broader Access to DataFrom Fitbits to insurance claims databases, we capture an enormous amount of...
Blog Post

Medicare Part D – A Beacon or a Warning Light?

The Medicare Part D prescription drug program has by nearly every measure been a success, but there is room for improvement, particularly when it...
Press Release

NPC Comments on CMS’ Announcement to Allow Broader Access to Publicly Funded Databases

(Washington, DC, June 2, 2015)—The National Pharmaceutical Council (NPC) today commented on the Centers for Medicare and Medicaid Services’ (CMS)...
Commentary and Testimony Page

NPC Comments on CMS' Proposed Changes to Protected Classes

March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of Health and Human Services200 Independence...
YouTube Videos

Comparative Effectiveness Research in Medicare Decision-Making

At the June 2011 Drug Information Association Annual Meeting, NPC asked Dr. Marcel Salive for his thoughts on how comparative effectiveness research...
Blog Post

#TBT: Value-Based Insurance Design & New Medicare Advantage Model

As part of our Throwback Thursday blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research...
Blog Post

CER Tweets of the Week: Study on Six Potential EBM “Biases”; VBID "Gets Its Medicare Close-up" (August 31-September 4)

This week on Twitter, comparative effectiveness research (CER) stakeholders shared a study examining six potential biases against patients and carers...
Blog Post

Medicare Part D – A Beacon or a Warning Light?

The Medicare Part D prescription drug program has by nearly every measure been a success, but there is room for improvement, particularly when it...
Blog Post

NPC Asks CMS to Consider Patients’ Individual Treatment Effects In Part D Rulemaking

The National Pharmaceutical Council (NPC) today asked the Centers for Medicare and Medicaid Services (CMS) to consider maintaining “protected classes...

Resources for Medicare Beneficiaries: Using Your Medicare Drug Plan | What to Do if Your Medicine Isn’t Covered

This 12-page publication helps Medicare Part D recipients and caregivers understand some of the...

Your Pharmacy Benefit: Make it Work for You!

This 16-page booklet offers helpful advice for those with prescription drug coverage through an...
Resources for Medicare Beneficiaries: Navigating the Coverage Gap | How the Gap May Affect You

Resources for Medicare Beneficiaries: Navigating the Coverage Gap | How the Gap May Affect You

This six-page brochure helps Medicare Part D recipients and caregivers better understand the...
  •  
  • 1 of 4
  • >